Former CIA Analyst Sue Mi Terry and Sung-Yoon Lee of Tufts University discuss factors contributing to President Trump canceling the summit in June with Kim Jong Un. …read more […]
ST PETERSBURG, Russia/MOSCOW (Reuters) – Russian aluminium producer Rusal has asked the Russian government to purchase some of its output, a government source said on Thursday, in an effort to alleviate the pain inflicted by U.S. sanctions.
(Reuters) – The United Auto Workers union (UAW) has filed a complaint accusing Tesla Inc Chief Executive Elon Musk of illegally threatening to take away benefits from workers who join the union.
(Reuters) – U.S. stocks fell on Thursday after President Donald Trump canceled a planned historic summit with North Korean leader Kim Jong Un and threatened tariffs on auto imports while trade tensions with China simmered.
(Reuters) – The United Auto Workers International Union (UAW) has filed a complaint accusing Tesla Inc Chief Executive Elon Musk of illegally threatening to take away benefits from workers who join the union.
In September, the federal government will mail a handbook on Medicare enrollment to 43 million households. “Medicare & You” is an important, authoritative source on a wide array of plan options for the annual enrollment period that runs from Oct. 15 through Dec. 7, and it has been mailed out to beneficiaries each year since 1999. The Medicare Rights Center and two other groups (Justice in Aging and the Center for Medicare Advocacy) argue that the draft contains inaccurate, ideologically tinted descriptions of the tradeoffs between original fee-for-service insurance …read more […]
(Reuters) – U.S. stocks tumbled on Thursday after President Donald Trump canceled a planned historic summit with North Korean leader Kim Jong Un, heightening concerns over his latest protectionist move as trade tensions with China simmer.
FRANKFURT (Reuters) – Deutsche Bank erroneously transferred 21 billion euros ($24.62 billion) to Macquarie in 2014, a spokesman said on Thursday, the latest such error to come to light.
(Reuters) – A Trump administration investigation of car and truck imports raised the threat on Thursday of renewed conflict over trade policy for an industry that thrives on stability and sent stocks in Asian and European automakers down.
NEW YORK (Reuters) – Criminals have stolen about $1.2 billion in cryptocurrencies since the beginning of 2017, as bitcoin’s popularity and the emergence of more than 1,500 digital tokens have put the spotlight on the unregulated sector, according to estimates from the Anti-Phishing Working Group released on Thursday.
PornHub is diversifying. The most popular site that no one you know will admit …read more […]
Editor’s Note: If you’ve kept up with your Investment U emails over the past few days, you’re aware that big changes are coming to your subscription.
But that’s really all I’ve told you. (And if you haven’t opened your emails lately, now’s a great time to do a quick skim!)
I promise to provide more details next week after Memorial Day. But for now, are you ready for a little game of Clue?
Pay close attention to the themes in today’s article by Nicholas.
Two key words should stand out… and will summarize our evolving brand and mission.
Can you guess which they are? Leave …read more […]
(Reuters) – U.S. stocks dropped on Thursday after President Donald Trump canceled a planned summit with North Korean leader Kim Jong Un, while a slide in oil prices and bank stocks also weighed as investors grappled with fresh U.S. protectionist plans.
(Reuters) – Pfizer Inc has agreed to pay $23.85 million to resolve allegations it illegally paid kickbacks to Medicare patients through a purportedly independent charitable foundation, the U.S. Department of Justice said on Thursday.
A month ago, Pfizer Inc. (NYSE:PFE) felt the sting of a somewhat surprising disappointment. Its biosimilar version of Herceptin, the popular breast cancer drug from Roche Holding AG (OTCMKTS:RHHBY), was rejected by the FDA.Biosimilar drugs are nearly-identical copies of a competitor’s product. It was a blow not just because Herceptin generated sales of more than $7 billion last year, but because it put the viability of Pfizer’s entire biosimilar program into question. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
